A phase II trial of a transmucosal herbal patch for the treatment of gingivitis

Journal of the American Dental Association

Volumn 142, Issue 10, 2011, Pages 1168-1175

  Grbic, John ^a   Wexler, Isaiah ^b   Celenti, Romi ^a   Altman, Jaclyn ^c   Saffer, Aron ^d  

^a Columbia University College of Dental Medicine ^*  (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF TORONTO   (Canada)

^d Izun Pharmaceuticals New York City   (United States)

Author keywords

Anti inflammatory agents; Gingival crevicular fluid; Gingival diseases; Herbal medicine

Indexed keywords

BETA GLUCURONIDASE; PLACEBO; PLANT EXTRACT;

ADULT; ARTICLE; BUCCAL DRUG ADMINISTRATION; CENTELLA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ECHINACEA; ENZYMOLOGY; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PERIODONTICS; PHASE 2 CLINICAL TRIAL; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SAMBUCUS NIGRA; TREATMENT OUTCOME;

ADMINISTRATION, BUCCAL; ADULT; CENTELLA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHINACEA; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; GINGIVITIS; GLUCURONIDASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIODONTAL INDEX; PHYTOTHERAPY; PLACEBOS; PLANT EXTRACTS; SAFETY; SAMBUCUS NIGRA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857415155     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2011.0086     Document Type: Article

References (39)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366(9499):1809-1820.
2. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002;29:177-206.
3. Cobb CM, Williams KB, Gerkovitch MM. Is the prevalence of periodontitis in the USA in decline? Periodontol 2000 2009;50:13-24.
4. Demmer RT, Papapanou PN. Epidemiologic patterns of chronic and aggressive periodontitis. Periodontol 2000 2010;53:28-44.
5. Kinane DF, Mark Bartold P. Clinical relevance of the host responses of periodontitis. Periodontol 2000 2007;43:278-293.
6. Scannapieco FA, Dasanayake AP, Chhun N. "Does periodontal therapy reduce the risk for systemic diseases?" Dent Clin North Am 2010;54(1):163-181.
7. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13(4):547-558.
8. Inaba H, Amano A. Roles of oral bacteria in cardiovascular diseases: from molecular mechanisms to clinical cases - implication of periodontal diseases in development of systemic diseases (published online ahead of print May 24, 2010). J Pharmacol Sci 2010;113(2): 103-109. doi:10.1254/jphs.09R23FM.
9. Goldenberg RL, Culhane JF. Preterm birth and periodontal disease. N Engl J Med 2006;355(18):1925-1927.
10. Chavarry NG, Vettore MV, Sansone C, Sheiham A. The relationship between diabetes mellitus and destructive periodontal dis- ease: a meta-analysis. Oral Health Prev Dent 2009;7(2):107-127.
11. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000;24:153-192.
12. Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000 2003;31:135-166.
13. Bascones A, Noronha S, Gomez M, Mota P, Gonzalez Moles MA, Villarroel Dorrego M. Tissue destruction in periodontitis: bacteria or cytokines fault? Quintessence Int 2005;36(4):299-306.
14. Graves DT. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 1999; 28(3):482-490.
15. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ. Chemo - kines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007;86(4):306-319.
16. Bhatavadekar NB, Williams RC. New directions in host modulation for the management of periodontal disease. J Clin Periodontol 2009;36(2):124-126.
17. Offenbacher S, Barros SP, Beck JD. Rethinking periodontal inflammation. J Periodontol 2008;79(8 suppl):1577-1584.
18. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008;79(8 suppl):1569-1576.
19. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007;65(1):1-13.
20. Paquette DW. Locally administered antimicrobials for the management of periodontal infection. Dent Today 2009;28(2):97-98, 100-101.
21. Harokopakis E, Albzreh MH, Haase EM, Scannapieco FA, Hajishengallis G. Inhibition of proinflammatory activities of major periodontal pathogens by aqueous extracts from elder flower (Sambucus nigra). J Periodontol 2006;77(2):271-279.
22. Mishima S, Saito K, Maruyama H, et al. Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull 2004;27(7):1004-1009.
23. Punturee K, Wild CP, Kasinrerk W, Vinitketkumnuen U. Immunomodulatory activities of Centella asiatica and Rhinacanthus nasutus extracts. Asian Pac J Cancer Prev 2005;6(3):396-400.
24. Sastravaha G, Gassmann G, Sangtherapitikul P, Grimm WD. Adjunctive periodontal treatment with Centella asiatica and Punica granatum extracts in supportive periodontal therapy. J Int Acad Periodontol 2005;7(3):70-79.
25. Woelkart K, Marth E, Suter A, et al. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharmacol Ther 2006;44(9): 401-408.
26. Löe H, Silness J. Periodontal disease in pregnancy, I: prevalence and severity. Acta Odontol Scand 1963;21:533-551.
27. Lamster IB, Holmes LG, Gross KB, et al. The relationship of ß-glucuronidase activity in crevicular fluid to probing attachment loss in patients with adult periodontitis: findings from a multicenter study. J Clin Periodontol 1995;22(1):36-44.
28. Centella asiatica [monograph]. Altern Med Rev 2007;12:69-72.
29. Cesarone MR, Incandela L, De Sanctis MT, et al. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model. Angiology 2001;52(suppl 2):S49-S54.
30. Kimura Y, Sumiyoshi M, Samukawa K, Satake N, Sakanaka M. Facilitating action of asiaticoside at low doses on burn wound repair and its mechanism (published online ahead of print Feb. 21, 2008). Eur J Pharmacol 2008;584(2-3):415-423. doi:10.1016/j.ejphar.2008.02.036.
31. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 2007; 43:85-101.
32. Matthias A, Banbury L, Stevenson LM, Bone KM, Leach DN, Lehmann RP. Alkylamides from echinacea modulate induced immune responses in macrophages. Immunol Invest 2007;36(2):117-130.
33. Kakagia DD, Kazakos KJ, Xarchas KC, et al. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers: a prospective randomized trial. J Diabetes Complications 2007;21(6):387-391.
34. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10(1):16-25.
35. Pastagia J, Nicoara P, Robertson PB. The effect of patientcentered plaque control and periodontal maintenance therapy on adverse outcomes of periodontitis. J Evid Based Dent Pract 2006;6(1):25-32.
36. Jeffcoat MK. Principles and pitfalls of clinical trials design. J Periodontol 1992;63(12 suppl):1045-1051.
37. Michalowicz BS, Novak MJ, Hodges JS, et al. Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes. J Periodontol 2009;80(11): 1731-1741.
38. Michalowicz BS, Hodges JS, DiAngelis AJ, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006;355(18):1885-1894.
39. Behle JH, Sedaghatfar MH, Demmer RT et al. Heterogeneity of systemic inflammatory responses to periodontal therapy (published online ahead of print March 11, 2009). J Clin Periodontol 2009;36(4): 287-294. doi:10.1111/j.1600- 051X.2009.01382.x.